Vivesto

Live-streamed R&D update regarding Paccal Vet

March 26, 2024

Read more
Annual Report 2023

April 23, 2024 (Only distributed in Swedish)

Read more
Interim Report Q2 2024

August 22, 2024
(Only distributed in Swedish)

Read the report
Interim Report Q3 2024

November 21, 2024
(Only distributed in Swedish)

Read the report

Vivesto signs Apealea option agreement with Zhida Pharmaceutical

November 7, 2024

CEO corner

Learn more (in Swedish)

Press releases

Non Regulatory November 11, 2024
Vivesto’s Paccal Vet receives Limited Market classification in EU
Regulatory November 7, 2024
Vivesto signs Apealea option agreement with Zhida Pharmaceutical
Non Regulatory July 1, 2024
Vivesto receives positive Cantrixil preclinical efficacy data

All press releases

Interim Report Q3 2024

Vivesto published its Q3 report for 2024 on November 21, 2024, at 08.00 am CET.

Report (in Swedish)

Read the report (in Swedish)

Calendar

November 21, 2024
Interim report Q3 2024
February 20, 2025
Year-end report 2024

The Share

Follow the share

Visit our Investor section

Annual Report 2023

Read the report